High-Dose (HD) Methotrexate (MTX) Induction Chemotherapy Followed by Alternative HD MTX-based and HD Cytarabine-based Combination Consolidation Chemotherapy for Newly Diagnosed Primary CNS Lymphoma; CISL 10-01 Study

CNS Lymphoma Clinical Trial

Official title:
Open-labeled, Multicenter Phase II Study of High-Dose (HD) Methotrexate (MTX) Induction Chemotherapy Followed by Alternative HD MTX-based and HD Cytarabine-based Combination Consolidation Chemotherapy for Newly Diagnosed Primary CNS Lymphoma; CISL 10-01 Study

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the complete response (CR) rate after HD-MTX induction chemotherapy followed by alternative HD MTX-based and HD Cytarabine-based combination consolidation chemotherapy

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01083342
Study type	Interventional
Source	Samsung Medical Center
Contact
Status	Completed
Phase	Phase 2
Start date	January 2010
Completion date	May 2012

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05117814` - Zanubrutinib Monotherapy in Relapsed/Refractory Central Nervous System Lymphoma	N/A
Terminated	`NCT05222269` - [68Ga]Ga-PentixaFor PET Imaging in CNS Lymphoma Patients	Phase 2
Recruiting	`NCT06132737` - [90Y]Y-PTT Endoradiotherapy in CNS Lymphoma Patients	Phase 1/Phase 2
Terminated	`NCT05242146` - GB5121 in Adult Patients With Relapsed/Refractory CNS Lymphoma	Phase 1
Not yet recruiting	`NCT06343311` - T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)	Phase 1/Phase 2
Completed	`NCT01319591` - Comparison of Creatinine Clearance Calculation for Estimation of GFR in Patients Receiving HD Methotrexate
Recruiting	`NCT05351593` - Tafasitamab Plus Lenalidomide in Relapsed CNS Lymphoma	Phase 1/Phase 2
Not yet recruiting	`NCT05828628` - CLIMB: CNS Lymphoma Imaging and Molecular Biomarkers Study
Completed	`NCT01182415` - High Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin's Lymphoma or Central Nervous System (CNS) Lymphoma	Phase 2
Recruiting	`NCT04841434` - A Phase I/II Study to Investigate the Use of VORAXAZE™ as Intended Intervention in Patients With CNSL	Phase 1/Phase 2
Completed	`NCT05293990` - Usefulness of Gadovist-enhanced FLAIR Imaging	N/A
Completed	`NCT00596154` - Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-dose Chemotherapy With Autologous Stem-cell Rescue in Newly-diagnosed Primary CNS Lymphoma	Phase 2
Recruiting	`NCT05926427` - Orelabrutinib Combined With Rituximab and Chemotherapy for Relapsed/Refractory B-Cell Lymphoma Patients With Central Nervous System Involvement	Phase 2